Eli Wallace

CEO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

BBOT

Current role

CEO, Board Member

2025-08-11–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	BridgeBio Oncology Therapeutics, Inc. (BBOT)	Former President and Chief Executive Officer	$571,850	$256,775	—	$7,646,920	$3,000,000	$14,000	$11,489,545
2024	BridgeBio Oncology Therapeutics, Inc. (BBOT)	Former President and Chief Executive Officer	$544,154	$237,600	—	$1,703,271	$2,000,000	$21,661	$4,463,320

Earnings-call appearances and filed executive appointments or departures, newest first.